James, Nicola
Regeneron (United States)
2 papers on CoChatORCID 0000-0002-1269-9811
Most cited papers
- Verified
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Marron, T. U., Fiel, M. I., Hamon, P., Fiaschi, N., Kim, E., Ward, S. C., Zhao, Z., Kim, J., Kennedy, P., Gunasekaran, G., et al. (2022) · The Lancet Gastroenterology & Hepatology
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers
Cited by 239
- Verified
Human sample authentication in biomedical research: comparison of two platforms
Manjunath, H. S., James, N., Mathew, R., Al Hashmi, M., Silcock, L., Biunno, I., De Blasio, P., Manickam, C., & Tomei, S. (2021) · Scientific Reports
Forensic and Genetic ResearchIdentification and Quantification in Food
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free